These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1510424)

  • 21. Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture.
    Black PL; Downs MB; Lewis MG; Ussery MA; Dreyer GB; Petteway SR; Lambert DM
    Antimicrob Agents Chemother; 1993 Jan; 37(1):71-7. PubMed ID: 8381640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles.
    Turpin JA; Terpening SJ; Schaeffer CA; Yu G; Glover CJ; Felsted RL; Sausville EA; Rice WG
    J Virol; 1996 Sep; 70(9):6180-9. PubMed ID: 8709244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The maturation steps of human immunodeficiency virus and the role of proteolysis].
    Bukrinskaia AG; Grigor'ev VB; Korablina EV; Gur'ev EL; Vorkunova GK
    Vopr Virusol; 2010; 55(1):10-5. PubMed ID: 20364665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.
    Mattei S; Flemming A; Anders-Össwein M; Kräusslich HG; Briggs JA; Müller B
    J Virol; 2015 Oct; 89(19):9739-47. PubMed ID: 26178992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    Misra A; Gleeson E; Wang W; Ye C; Zhou P; Kimata JT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication.
    Venaud S; Yahi N; Fehrentz JL; Guettari N; Nisato D; Hirsch I; Chermann JC
    Res Virol; 1992; 143(5):311-9. PubMed ID: 1480823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
    Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
    Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral inhibition of the HIV-1 capsid protein.
    Tang C; Loeliger E; Kinde I; Kyere S; Mayo K; Barklis E; Sun Y; Huang M; Summers MF
    J Mol Biol; 2003 Apr; 327(5):1013-20. PubMed ID: 12662926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
    Bryant ML; Ratner L; Duronio RJ; Kishore NS; Devadas B; Adams SP; Gordon JI
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2055-9. PubMed ID: 2006142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor.
    el-Farrash MA; Kuroda MJ; Kitazaki T; Masuda T; Kato K; Hatanaka M; Harada S
    J Virol; 1994 Jan; 68(1):233-9. PubMed ID: 8254733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
    Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
    Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein.
    Rayner MM; Cordova BC; Meade RP; Aldrich PE; Jadhav PK; Ru Y; Lam PY
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1635-40. PubMed ID: 7979297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T cells.
    Lee YM; Yu XF
    Virology; 1998 Mar; 243(1):78-93. PubMed ID: 9527917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
    Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
    Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
    Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.
    Mak J; Jiang M; Wainberg MA; Hammarskjöld ML; Rekosh D; Kleiman L
    J Virol; 1994 Apr; 68(4):2065-72. PubMed ID: 7511167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.
    Bechtold CM; Patick AK; Alam M; Greytok J; Tino JA; Chen P; Gordon E; Ahmad S; Barrish JC; Zahler R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):374-9. PubMed ID: 7726501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.